Redox, cysteines, and kinases-A triad sustaining myeloid leukemia
- PMID: 39306364
- DOI: 10.1016/bs.acr.2024.04.008
Redox, cysteines, and kinases-A triad sustaining myeloid leukemia
Abstract
Reactive oxygen species (ROS) work as a second messenger, modulating cell response and establishing homeostasis. Abrupt changes in ROS are used to modulate transient cell response to different stimuli, from viral infection to inflammation. Chronic exposure to high ROS concentration can cause cellular damage and promote the development of diseases. Leukemogenesis is adapted to high concentrations of ROS, hijacking the ROS system, and uses kinase cascades to promote survival advantages. The oxidation-reduction (redox) machinery is composed of enzymes that orchestrate all classes of protein and use available Cys as transmitters and sensors, to disseminate stress signals through cells via kinase cascades. Myeloid leukemias (MLs) are known for being a heterogeneous disease, and clonal diversity is remarkably characterized by differences in the activation of kinase-regulated signaling cascades to provide survival advantage. Stress-activated kinase cascades and other cascades are regulated by the ROS system. Several studies present nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) and the ER-resident NOX4 as key elements of ROS activity in healthy myeloid cells and myeloid leukemia. Targeting ROS presents an attractive therapeutic strategy for (MLs) patients, but the boundaries between pro-apoptotic and anti-apoptotic ROS concentrations are not well established. Detailed understanding of the signaling switches that determine cell fate needs to be well understood. This work explores several aspects of the redox system and thiol-mediated reactions with focus on kinase signaling in myeloid cancers and highlights some of the challenges.
Keywords: Cysteines; Kinases; Myeloid leukemia; Post-translational modification; Reactive oxygen species; Redox.
Copyright © 2024. Published by Elsevier Inc.
Similar articles
-
Do reactive oxygen species play a role in myeloid leukemias?Blood. 2011 Jun 2;117(22):5816-26. doi: 10.1182/blood-2011-01-326025. Epub 2011 Mar 11. Blood. 2011. PMID: 21398578 Review.
-
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate.Blood. 2010 Oct 14;116(15):2732-41. doi: 10.1182/blood-2009-11-256354. Epub 2010 Jun 21. Blood. 2010. PMID: 20566897 Free PMC article.
-
Localizing NADPH oxidase-derived ROS.Sci STKE. 2006 Aug 22;2006(349):re8. doi: 10.1126/stke.3492006re8. Sci STKE. 2006. PMID: 16926363 Review.
-
Cysteines under ROS attack in plants: a proteomics view.J Exp Bot. 2015 May;66(10):2935-44. doi: 10.1093/jxb/erv044. Epub 2015 Mar 5. J Exp Bot. 2015. PMID: 25750420 Review.
-
H2O2 oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes.J Biol Chem. 2018 Oct 19;293(42):16376-16389. doi: 10.1074/jbc.RA118.004613. Epub 2018 Sep 6. J Biol Chem. 2018. PMID: 30190325 Free PMC article.
Cited by
-
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?Front Pharmacol. 2024 Sep 20;15:1441938. doi: 10.3389/fphar.2024.1441938. eCollection 2024. Front Pharmacol. 2024. PMID: 39372214 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous